This brief describes the advocacy efforts, led by Ipas Pakistan and local partners, to integrate WHO-approved approaches (UE methods and training of additional cadres of providers) into the healthcare system. In particular, it details the work done to establish the Punjab Reproductive Health Technology Assessment Committee (PRHTAC)—a provincial body formed to review existing evidence on UE technologies, address concerns about stigma, examine a legal basis for clinical expansion to MLPs, consider the financial implications of new technologies, and, ultimately, to make recommendations/changes for the adoption of misoprostol and MVA into the local healthcare system.